发明授权
- 专利标题： Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
- 专利标题（中）： 使用GPR119受体识别夹心促分泌素的方法
-
申请号： US11989037申请日： 2007-04-10
-
公开(公告)号： US07833730B2公开(公告)日： 2010-11-16
- 发明人: Zhi-Liang Chu , James N. Leonard
- 申请人： Zhi-Liang Chu , James N. Leonard
- 申请人地址： US CA San Diego
- 专利权人： Arena Pharmaceuticals, Inc.
- 当前专利权人： Arena Pharmaceuticals, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Fish & Richardson P.C.
- 国际申请： PCT/US2007/008902 WO 20070410
- 国际公布： WO2007/120689 WO 20071025
- 主分类号： G01N33/53
- IPC分类号： G01N33/53 ; G01N33/567
摘要：
The present invention relates to methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual. Agonists of GPR119 receptor are useful as therapeutic agents for treating or preventing a condition characterized by low bone mass, such as osteoporosis, and for increasing bone mass in an individual. Agonists of GPR119 receptor promote bone formation in an individual.
公开/授权文献
信息查询
IPC分类:
